Description
BPC-157 + TB-500 UK 10mg Research Peptide Blend
BPC-157 + TB-500 UK 10mg is supplied by SPX Labs as a research peptide blend for legitimate laboratory research, analytical testing and scientific evaluation. The nominal presentation contains 5mg BPC-157 and 5mg TB-500.
Each product carries an identifiable batch reference designed to support traceability between the supplied research material and analytical documentation associated with that batch.
BPC-157 + TB-500 UK Research Material
This research material combines BPC-157 and TB-500 within a single lyophilised presentation. The two components originate from distinct areas of experimental peptide research and should be considered individually when reviewing scientific literature and analytical information.
SPX Labs supplies this blend exclusively as a laboratory research material. It is not supplied as a medicine, supplement or therapeutic product, and SPX Labs does not provide instructions for human or veterinary administration.
Product Profile & Specifications
Product: BPC-157 + TB-500
Nominal total quantity: 10mg
BPC-157: 5mg nominal presentation
TB-500: 5mg nominal presentation
Format: Lyophilised (freeze-dried) research material
Supplier: SPX Labs
Intended use: Laboratory research, analytical testing and scientific evaluation only
Batch identification: Provided on supplied material
Documentation: Batch-specific information available where applicable
The stated quantities represent the nominal SPX Labs product presentation. Where analytical testing has been performed, experimentally reported component content should be considered separately from the nominal quantities.
Analytical Testing & Batch Documentation
SPX Labs prioritises batch traceability and analytical transparency. Analytical information is associated with the relevant identifiable batch rather than being presented as a universal specification covering every BPC-157 + TB-500 research blend.
SPX batch SPX-BPCTB10-001 is associated with supporting analytical documentation reporting:
Reported BPC-157 content: 6.00mg
Reported TB-500 content: 5.38mg
Reported combined peptide content: 11.38mg
Reported peptide purity: Not reported
SPX batch reference: SPX-BPCTB10-001
Relative to the nominal 5mg + 5mg presentation, the reported results correspond to approximately 120.0% for BPC-157, 107.6% for TB-500 and 113.8% combined content.
Both reported component-content results fall within the provisional SPX internal commercial research-material content range of 90–120% of the stated label claim. However, peptide purity was not reported in the supporting analytical documentation.
For that reason, this batch should not be represented as having passed the complete SPX analytical release criteria. Its batch documentation records content criteria: PASS, while noting that the purity criterion could not be assessed from the available report.
These analytical results relate specifically to the analysed sample associated with this batch and should not be interpreted as a guarantee that every past or future batch will produce identical results.
Researchers can review the available record through the SPX Labs COA Library and the linked batch-report page.
Understanding Blend Analytical Information
Analytical assessment of a multi-component peptide research material requires consideration of the individual analytes actually reported by the laboratory. A result relating to one component should not automatically be interpreted as confirmation of another component or of the complete blend.
Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry may be used within peptide analysis depending on the analytical objective and method selected.
Reported peptide content and reported peptide purity describe different analytical characteristics. A content measurement does not itself establish chromatographic purity, and a purity result does not itself establish the amount of peptide present.
Furthermore, neither content nor chromatographic purity alone establishes sterility, endotoxin status, pharmaceutical approval, clinical efficacy or suitability for human or veterinary use.
SPX Labs therefore presents the available results as batch-specific research-material documentation and clearly identifies analytical parameters that were not reported.
BPC-157 + TB-500 Batch Traceability
Each BPC-157 + TB-500 research material supplied by SPX Labs carries an identifiable SPX batch reference designed to connect the material with relevant batch information and applicable supporting documentation.
Researchers should retain this reference when reviewing analytical information, using the SPX batch-verification system or contacting SPX Labs regarding a particular product.
The SPX Labs Quality & Testing section explains the approach used for batch identification, analytical documentation and SPX internal research-material release criteria.
This batch-focused approach helps prevent analytical results from a standalone peptide, another blend or an unrelated batch from being incorrectly attributed to this material.
Scientific Research Context
BPC-157 and TB-500 are distinct peptide research materials. Scientific information relating to either component should therefore be evaluated independently rather than assuming that experimental observations concerning one peptide automatically characterise the combined material.
BPC-157 has been described in peer-reviewed experimental literature as a 15-amino-acid peptide. Researchers can consult the early BPC-157 research indexed by PubMed for scientific background concerning that peptide.
TB-500 is commonly discussed in relation to thymosin beta-4 research. Researchers should distinguish the specific identity of the supplied research material from the broader scientific literature concerning thymosin beta-4 and related peptide sequences.
SPX Labs does not present experimental findings concerning either component as established clinical outcomes or as evidence concerning the intended use of this combined research material.
Storage & Laboratory Handling
Store the research material in accordance with the storage and handling information supplied with the applicable batch.
Appropriate laboratory procedures should be followed when handling research materials, and unnecessary exposure to adverse environmental conditions should be avoided.
Researchers and laboratories remain responsible for determining appropriate handling, storage and experimental procedures for their particular research environment and intended analytical application.
Frequently Asked Questions
What does the 10mg presentation contain?
The nominal presentation contains 5mg BPC-157 and 5mg TB-500, providing a nominal combined quantity of 10mg.
Is batch-specific analytical documentation available?
Yes. SPX-BPCTB10-001 has supporting analytical documentation reporting 6.00mg BPC-157 and 5.38mg TB-500 for the analysed sample.
Was peptide purity reported for SPX-BPCTB10-001?
No. Peptide purity was not reported in the supporting documentation for this batch. SPX Labs therefore does not assign a purity result to the batch or represent it as satisfying the complete SPX analytical release criteria.
Does this batch pass SPX content criteria?
The reported component contents fall within the provisional SPX internal commercial research-material content range of 90–120% of the respective nominal label claims. This is an SPX internal commercial acceptance criterion and is not represented as a pharmacopoeial, regulatory or universal peptide-industry standard.
Can standalone BPC-157 or TB-500 results be used for this blend?
No. Analytical results should be associated with the specific material, analyte, sample and batch identified in the supporting documentation.
Is this research blend supplied for human use?
No. SPX Labs supplies this material exclusively for legitimate laboratory research, analytical testing and scientific evaluation. It is not supplied for human or veterinary consumption or administration.
Laboratory Research Notice
BPC-157 + TB-500 supplied by SPX Labs is intended strictly for legitimate in-vitro laboratory research, analytical testing and scientific evaluation.
It is not supplied for human or veterinary consumption or administration and is not intended to diagnose, treat, cure or prevent disease.
SPX Labs — Precision Research. Verified Quality.
spxlabs.co.uk | info@SPXLabs.co.uk
